ZAID BAHA: Open Payments
NPI 1447604608 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,013 in 36 payments from 8 companies in 2025. Trend: 2023 $846 · 2024 $4,395 · 2025 $8,013
Speaker / faculty: $7,070Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $4,684 |
| ABBVIE INC. | 2 | $2,479 |
| E.R. Squibb & Sons, L.L.C. | 10 | $331 |
| Alkermes, Inc. | 14 | $273 |
| Janssen Pharmaceuticals, Inc | 2 | $139 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: UZEDY, VRAYLAR, ARISTADA, COBENFY, INVEGA, ABILIFY ASIMTUFII, TRINTELLIX, ERZOFRI EXTENDED-RELEASE.
Industry payments across MI — which companies pay providers there.
